Exelixis | Lngresos Netos



Net Income Cambio Fecha
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Bayer EUR -335000000 3.85B 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Eisai JPY 23.79B 12.68B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Exelixis USD 139.86M 21.89M 2025-01
Genmab DKK 3.84B 2.58B 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 201.21M 94.76M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
Merck USD 3.74B 586M 2024-12
Moderna USD -1120000000 1.13B 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Takeda JPY 23.79B 68.26B 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Xencor USD -53479000 8.34M 2024-12



Exelixis Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.